Europe — EMA

Simulect (Basiliximab)

Request sourcing

1

Pack/s

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →

Product details

Drug

Basiliximab

Route

Intravenous Use

Manufacturer

Novartis Europharm Limited

Origin

EU

Related products

Simulect 20 mg/5mL

Simulect 20 mg/5mL

Basiliximab · 20 mg/5 mL

INJECTION, POWDER, FOR SOLUTION

Novartis Pharmaceuticals Corporation

Simulect 10 mg/2.5mL

Simulect 10 mg/2.5mL

Basiliximab · 10 mg/2.5 mL

INJECTION, POWDER, FOR SOLUTION

Novartis Pharmaceuticals Corporation

Simulect 20 mg

Simulect 20 mg

Basiliximab · 20 MG

POWDER FOR SOLUTION

NOVARTIS PHARMACEUTICALS CANADA INC

Simulect

Simulect

Basiliximab

Novartis Europharm Limited